Publications

Found 83 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Lukin DJ, Funez-dePagnier G, Lima S, Lai D, Duenas-Bianchi L, Ahmed W, Jacob V, Battat R, Scherl E, Longman RS.  2021.  No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.. Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
M
Ma C, Sedano R, Almradi A, Casteele NVande, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R et al..  2021.  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.. Gastroenterology. 160(7):2291-2302.
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
Mon KJoy Yee, J Blander M.  2023.  TAP-ing into the cross-presentation secrets of dendritic cells.. Curr Opin Immunol. 83:102327.
Monticelli LA, Diamond JM, Saenz SA, Wojno EDTait, Porteous MK, Cantu E, Artis D, Christie JD.  2020.  Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.. Am J Respir Crit Care Med. 201(1):63-72.
N
Nwosu BUdoka, Parajuli S, Jasmin G, Fleshman J, Sharma RB, Alonso LC, Lee AF, Barton BA.  2022.  Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial.. J Endocr Soc. 6(1):bvab179.
P
Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis.
R
Rajan A, Pan Y, Mahtani P, Niec R, Longman R, Gerber J, Lukin D, Scherl E, Battat R.  2023.  The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.. Crohns Colitis 360. 5(2):otad017.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V et al..  2021.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.. Cell Metab. 33(11):2174-2188.e5.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y et al..  2021.  Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance.. medRxiv.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V et al..  2021.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.. Cell Metab. 33(12):2484.
S
Sandoval DA, Alonso LC, Gannon M, Sander M, Sussel L, Reusch JEB.  2021.  Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent.. Diabetes Care. 44(8):1744-1747.
Sharma RB, Landa-Galván HV, Alonso LC.  2021.  Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells.. Diabetes. 70(11):2431-2443.
Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J et al..  2021.  Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.. Lancet Gastroenterol Hepatol. 6(10):826-849.
Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP et al..  2022.  Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.. Lancet Gastroenterol Hepatol. 7(1):69-95.
Shukla AP, Tchang BG, Lam T, Steller I, Touhamy S, Askin G, Curanaj FAMendelso, Seley JJ, Lorber D, Safford MM et al..  2021.  Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.. J Diabetes Complications. 35(8):107967.
Skovsø S, Panzhinskiy E, Kolic J, Cen HHoward, Dionne DA, Dai X-Q, Sharma RB, Elghazi L, Ellis CE, Faulkner K et al..  2022.  Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance.. Nat Commun. 13(1):735.
Smith ES, Chen J, Pan Y, Mahtani P, Lukin D, Ahmed W, Longman R, Burakoff R, Scherl E, Battat R.  2023.  The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.. J Clin Gastroenterol.
Snyder JT, Darko C, Sharma RB, Alonso LC.  2021.  Endoplasmic Reticulum Stress Induced Proliferation Remains Intact in Aging Mouse β-Cells.. Front Endocrinol (Lausanne). 12:734079.
T
Tchang BG, Askin G, Sahagun A, Hwang J, Huang H, Curanaj FAMendelso, Seley JJ, Safford MM, Alonso LC, Aronne LJ et al..  2021.  The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.. Obesity (Silver Spring). 29(6):971-975.
Teng F, Tachó-Piñot R, Sung B, Farber DL, Worgall S, Hammad H, Lambrecht BN, Hepworth MR, Sonnenberg GF.  2021.  ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.. Cell Rep. 37(8):110051.
Topczewska PM, Rompe ZA, Jakob MO, Stamm A, Leclère PS, Preußer A, Duerr CU, Thole LMarie Laur, Kotsch K, Artis D et al..  2023.  ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.. Front Immunol. 14:1130933.
V
Vatter FAPelissie, Cioffi M, Hanna SJ, Castarede I, Caielli S, Pascual V, Matei I, Lyden D.  2021.  Extracellular vesicle- and particle-mediated communication shapes innate and adaptive immune responses.. J Exp Med. 218(8)
Venturelli OS, Wang HH, Estrela S, Huang KCasey, Ledesma-Amaro R, Fedorec AJH, Stecher B, Lawson CE, Zarrinpar A, Guo C-J et al..  2023.  What is the key challenge in engineering microbiomes? Cell Syst. 14(2):85-90.
Viladomiu M, Longman RS.  2021.  Decoding the matrix: multiomics reveals host-microbe biomarker for inflammatory bowel disease.. J Clin Invest. 131(9)